Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Archives

Targeting the 5-HT2A receptor with psychedelics & novel molecules

Dive into the world of 5-HT2A receptor modulation, DMPK, and novel psychedelics. Learn how these aspects impact therapeutic responses and discover our exciting research at SfN 2023.

Alzheimer’s disease and neurodegeneration: A brighter outlook?

Alzheimer’s disease (AD) is a devastating disease for the patient, their family and friends, and also their community and wider...
View Article

To hallucinate, or not to hallucinate – that is the question

The explosion of research interest, clinical development and funding of psychedelic therapeutics for disorders such as depression, PTSD and substance...
View Article

Effective Strategies for Successful Hit Identification in Drug Discovery

Discover effective hit identification strategies in drug discovery at Sygnature Discovery. Explore knowledge-based hit generation, High Throughput Screening (HTS), large database virtual screening, and fragment-based screening. Our expert scientists can guide your project to success.